Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow—a long-term follow-up

Autor: Diel, I.J. *, Jaschke, A., Solomayer, E.F., Gollan, C., Bastert, G., Sohn, C., Schuetz, F.
Zdroj: In Annals of Oncology December 2008 19(12):2007-2011
Databáze: ScienceDirect